Literature DB >> 21970960

Helicobacter pylori: 14-day triple therapy may be the optimal empirical therapy for Helicobacter pylori eradication in Latin American populations.

Katherine Smith.   

Abstract

Entities:  

Year:  2011        PMID： 21970960     DOI： 10.1038/nrgastro.2011.146

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial.

Authors:  E Robert Greenberg; Garnet L Anderson; Douglas R Morgan; Javier Torres; William D Chey; Luis Eduardo Bravo; Ricardo L Dominguez; Catterina Ferreccio; Rolando Herrero; Eduardo C Lazcano-Ponce; María Mercedes Meza-Montenegro; Rodolfo Peña; Edgar M Peña; Eduardo Salazar-Martínez; Pelayo Correa; María Elena Martínez; Manuel Valdivieso; Gary E Goodman; John J Crowley; Laurence H Baker
Journal:  Lancet       Date:  2011-07-21       Impact factor: 79.321
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.